Comprehensive Analytical Method Development, Botanical Chemical Profiling, and Full SAHPRA/CTD Regulatory Compliance for Active Ingredients, Natural Health Products, and Finished Dosage Forms.
Engineered specifically to solve chromatographic separation complexities, potency assays, and safety profiles conforming to South African Health Products Regulatory Authority (SAHPRA) protocols.
Fully validated HPTLC, HPLC-DAD, and GC-MS quantitative protocols designed for complex botanical matrices and chemical reference standard isolation.
Explore Analytical Method
GLP-compliant in vivo pharmacokinetic profiles, acute toxicological assays, and biological potency models tailored for CAMS registrations.
View Preclinical Services
High-resolution chromatographic fingerprinting, method transfer, and ICH Q2(R2) analytical validation packages for international dossiers.
Review Method Validation
High-throughput cellular assays, anti-inflammatory and metabolic enzymatic screening protocols accelerating discovery go/no-go milestones.
Access In Vitro TestingIn modern biopharmaceutical manufacturing, phytomedicine, and nutraceutical trade, the validity of an active chemical claim depends strictly on the robustness of its underlying testing methodology. In the Republic of South Africa, the landscape of commercial manufacturing is transitioning through an unprecedented regulatory transformation. The enforcement of rigorous compliance frameworks overseen by the South African Health Products Regulatory Authority (SAHPRA) under the Medicines and Related Substances Act (Act 101 of 1965), particularly concerning Category D (Complementary Medicines - CAMS) and Category A pharmaceuticals, demands that commercial entities present unequivocal analytical verification of identity, purity, potency, and stability.
Historically, reliance on non-specific titrations or outdated gravimetric testing has exposed suppliers and distributors to grave regulatory non-compliance, inter-batch inconsistency, and intellectual property vulnerabilities. As a premier ODM analysis method establishing supplier, Yineng Pharma (MedGence) bridges the technical gap between sophisticated chromatographic discovery and commercial manufacturing, ensuring every botanical extract, synthetic entity, or active pharmaceutical ingredient (API) is governed by validated, audit-ready analytical methodologies.
The tightening of safety, efficacy, and quality criteria for herbal substances requires South African importers and brand holders to validate active markers via validated HPLC/UHPLC frameworks.
Rich botanical reservoirs such as Aspalathus linearis (Rooibos), Pelargonium sidoides, Harpagophytum procumbens (Devil’s Claw), and Sceletium tortuosum require complex chemometric profiling.
South Africa serves as the primary gateway into the broader Southern African Development Community (SADC). Robust analytical dossiers ensure swift reciprocal trade registrations.
The South African commercial market holds a unique dual position in the global economy. On one hand, it represents an advanced manufacturing and distribution hub for multinational pharmaceutical enterprises based in Gauteng, Western Cape, and KwaZulu-Natal. On the other hand, it is the custodian of extraordinary floral biodiversity. However, localized manufacturing operations frequently encounter significant technical roadblocks:
Our structured ODM method development pathway takes your chemical candidate or natural medicine from preliminary matrix characterization to globally certifiable quality control execution.
Standardizing botanical identity through standardized HPTLC fingerprinting under controlled relative humidity. Includes specific chemical derivatization and digital multi-wavelength Rf verification designed for rapid incoming raw material inspection.
Sub-2-micron particle stationary phase separation enabling high-speed, baseline-resolved quantification of multi-component active ingredients, isobaric flavonoids, glycosides, and trace contaminants down to parts-per-billion (ppb) thresholds.
Optimized headspace and direct-injection gas chromatography protocols engineered for essential oils, terpene fraction isolation, residual solvent quantification (ICH Q3C), and volatile fatty acid characterization.
Our analytical method establishment protocols do not simply generate chromatograms; they deliver comprehensive validation portfolios fulfilling international scientific consensus. Every method developed for our South African and global partners is validated across critical performance parameters:
The global botanical and active ingredient sector is undergoing rapid convergence toward standardized chemical profiling. International bodies, including the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and the World Health Organization (WHO), have moved away from broad crude drug definitions toward strict, multi-marker active fingerprinting. In the international marketplace, products lacking validated assay profiles face immediate quarantine, import alerts, or regulatory rejection.
By engaging with Yineng Pharma as an ODM partner, South African suppliers gain access to analytical methodologies that seamlessly integrate with international dossiers. We employ computerized chromatographic fingerprint similarity evaluations (Chinese Pharmacopoeia and WHO reference frameworks), providing our clients with mathematical similarity scores (>0.95) across multi-origin supply batches. This shields brand owners against raw material seasonal variations and safeguards long-term commercial reputation.
Full provision of Quality (Module 3) documentation, encompassing 3.2.S Drug Substance and 3.2.P Drug Product analytical method validation reports formatted for SAHPRA submission.
Seamless transfer of testing procedures to local South African QC laboratories (Cape Town, Johannesburg, Durban), supported by comparative inter-laboratory validation runs.
Stability-indicating analytical methods capable of resolving degradation compounds under 40°C ± 2°C / 75% RH ± 5% RH conditions required across Southern Africa.
Under our entrusted contract development and manufacturing (ODM/CDMO) model, client confidentiality is preserved under rigorous bilateral Non-Disclosure Agreements (NDAs). Proprietary extraction parameters, patented fraction ratios, and chemical isolation techniques developed for your South African brand remain exclusively yours. We provide complete analytical ownership, enabling your organization to file local or international patents without encumbrance.
Application: Commercializing Pelargonium sidoides root extract or Harpagophytum procumbens for clinical cold remedies and joint health.
ODM Solution: Established baseline HPLC assay protocols quantifying Umckalin and Harpagoside with complete matrix clean-up, eliminating false positives caused by related iridoid glycosides.
Application: Brand owners distributing multi-herbal capsules and oral liquids via national pharmaceutical retail chains (e.g., Dis-Chem, Clicks).
ODM Solution: Designed high-throughput UHPLC methods capable of concurrent quantitative assay of multiple water- and fat-soluble active markers in a single chromatographic run.
Application: Formulation of high-efficacy cosmeceutical skin serums incorporating botanical antioxidants and polyphenol fractions.
ODM Solution: Established stability-indicating UV-Vis and HPLC assays monitoring active compound retention in emulsion bases over real-time and accelerated shelf life.
Pioneering next-generation analytical sciences to accelerate development timelines and minimize environmental footprint across global supply partnerships.
Clear answers regarding analytical feasibility, regulatory registration, method transfer, and intellectual property safety.
From preliminary plant screening to full Phase I–IV clinical investigations and batch manufacturing, explore our end-to-end service capabilities.
Comprehensive chemical marker identification, quantitative assay validation, and chromatographic fingerprinting for pharmaceuticals.
View Method Service
Preclinical animal bioassays, in vivo pharmacological efficacy profiles, and chronic/acute toxicity models for regulatory filing.
View Animal Studies
Target-specific cellular assays, metabolic pathway profiling, and high-throughput screening confirming biological mechanisms.
View In Vitro Services
Human safety, pharmacokinetic, dose-escalation, and double-blind multicenter therapeutic trials supporting NDA registrations.
Explore Clinical Trials
Phytochemical screening, high-density yield profiling, and selective solvent partitioning for new botanical candidates.
Explore Plant Screening
Multi-origin geographical mapping, seasonal harvest window determination, and phytochemical potency benchmarking.
View Potency Studies
HPLC, UHPLC, and GC chromatographic optimization providing stability-indicating specificity and batch-release precision.
Request Technical Specs
In vivo toxicology, LD50, genotoxicity tests, and target organ assessment ensuring uncompromised consumer product safety.
Request Safety Profile